Placebo IV Clinical Trials

3 actively recruiting trials across 1 location

Also known as: Toripalimab placebo

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1

Top Sponsors

Shanghai Junshi Bioscience Co., Ltd.1
Sanofi1
Eli Lilly and Company1

Indications

Systemic Lupus Erythematosus1
Diabetes Mellitus, Type 11
Lupus1
Diabetes1
Healthy1

Other2 trials

A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

Phase 1

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

Phase 3

Vestavia Hills, Alabama1 trial

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

Accel Research Sites Network - Vestavia Hills- Site Number : 8400003

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.